BACKGROUND/AIM: Current pathologic assessment of colorectal cancer (CRC) does not account for tumor heterogeneity, yet biologically important signals are embedded in morphologic differences that can drive patient prognosis…
SOCIETY: AGA Join this session to review current and future applications for AI in assessing GI cancer risk, and guiding cancer screening and cancer therapeutics in research and clinical care settings…